BioRem Inc.
BRM.V · TSXV
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | CA$3,044 | CA$2,179 | CA$1,613 | CA$1,297 |
| Dep. & Amort. | CA$473 | CA$383 | CA$351 | CA$344 |
| Deferred Tax | CA$383 | CA$459 | CA$84 | CA$382 |
| Stock-Based Comp. | CA$143 | CA$128 | CA$94 | CA$8 |
| Change in WC | -CA$441 | -CA$2,742 | -CA$736 | CA$1,700 |
| Other Non-Cash | CA$83 | CA$84 | CA$40 | CA$51 |
| Operating Cash Flow | CA$3,685 | CA$490 | CA$1,445 | CA$3,782 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -CA$372 | -CA$553 | -CA$203 | -CA$76 |
| Net Acquisitions | CA$0 | CA$0 | CA$0 | CA$0 |
| Inv. Purchases | CA$0 | CA$0 | CA$0 | CA$0 |
| Inv. Sales/Matur. | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Inv. Act. | CA$0 | CA$0 | CA$0 | CA$0 |
| Investing Cash Flow | -CA$372 | -CA$553 | -CA$203 | -CA$76 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -CA$548 | -CA$1,301 | -CA$734 | CA$0 |
| Stock Issued | CA$157 | CA$69 | CA$2 | CA$0 |
| Stock Repurch. | CA$0 | CA$0 | CA$0 | -CA$12,411 |
| Dividends Paid | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Fin. Act. | -CA$181 | -CA$97 | -CA$220 | CA$4,855 |
| Financing Cash Flow | -CA$572 | -CA$1,329 | -CA$952 | -CA$7,556 |
| Forex Effect | CA$180 | -CA$91 | -CA$986 | -CA$548 |
| Net Chg. in Cash | CA$2,921 | -CA$1,483 | -CA$696 | -CA$4,398 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CA$2,292 | CA$3,775 | CA$4,471 | CA$8,869 |
| End Cash | CA$5,213 | CA$2,292 | CA$3,775 | CA$4,471 |
| Free Cash Flow | CA$3,313 | -CA$63 | CA$1,242 | CA$3,706 |